WRBY Warby Parker Inc.

NYSE Ophthalmic Goods DE CIK: 0001504776
AI RATING
HOLD
72% Confidence

Investment Thesis

Warby Parker demonstrates solid revenue growth of 13% YoY with healthy gross margins of 54%, but this strength is undermined by critically weak operating profitability with just 0.7% operating margin and only 0.8% ROE. The fortress balance sheet with $288M cash and zero debt provides financial stability, but the company must demonstrate material margin expansion to justify investment given its poor capital efficiency.

Strengths

  • + Solid revenue growth momentum at 13% YoY with no deceleration
  • + Strong gross margins of 54% indicate healthy unit economics before operating expenses
  • + Fortress balance sheet: $288.2M cash, zero long-term debt, 2.33x current ratio, and Debt/Equity of 0.0x
  • + Positive operating and free cash flow generation demonstrates underlying business viability

Risks

  • ! Critically thin operating margin of 0.7% despite 54% gross margins indicates severe SG&A burden and potential structural profitability challenges
  • ! Abysmal capital returns with ROE of 0.8% and ROA of 0.4% for $736M asset company suggests value destruction
  • ! Weak cash conversion with FCF margin of only 3.5% versus revenue growth, indicating high customer acquisition costs or competitive pressures
  • ! Net income of only $3.2M on $242M revenue is indefensible margin performance and raises questions about unit economics sustainability

Key Metrics to Watch

Financial Metrics

Revenue
242.4M
Net Income
3.2M
EPS (Diluted)
$0.03
Free Cash Flow
8.4M
Total Assets
736.4M
Cash
288.2M

Profitability Ratios

Gross Margin 54.0%
Operating Margin 0.7%
Net Margin 1.3%
ROE 0.8%
ROA 0.4%
FCF Margin 3.5%

Balance Sheet & Liquidity

Current Ratio
2.33x
Quick Ratio
2.03x
Debt/Equity
0.00x
Debt/Assets
49.0%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-09T13:53:36.263343 | Data as of: 2026-03-31 | Powered by Claude AI